~~<i id='EA07DCA3CD'><strike id='EA07DCA3CD'><tt id='EA07DCA3CD'><pre id='EA07DCA3CD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：hotspot 2025-09-30 15:15:33 - browse：5159

illustration of osteoarthritis in the knee joint -- chronic disease health coverage from STAT — Adobe

A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of cartilage that’s characteristic of osteoarthritis.

In a new study, published in Science Translational Medicine on Wednesday, researchers analyzed tissue samples and joint fluid from 12 people, both those with osteoarthritis and healthy controls. They found those with osteoarthritis in their knee had a fourfold increase in apolipoprotein E, or APOE.

Despite being common, the how of osteoarthritis has mostly eluded scientists. The new research offers a novel idea with an unlikely protein.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA panel endorses Alnylam’s heart drug — after picking it apart

knowledge

focus

hotspot

entertainment

hotspot

AdobeTheFoodandDrugAdministrationhasclearedOtsukaPharmaceutical’sdigitaltreatmentformajordepressived

WSS

Oral obesity drug from Viking Therapeutics hits key early target

FDA panel endorses Alnylam’s heart drug — after picking it apart

New weight loss drugs vying to be the next Wegovy or Mounjaro

Acelyrin, a rare IPO success, stumbles in its first big test

UnitedHealth, in a surprise, takes aim at Steward’s physician group

UnitedHealth, in a surprise, takes aim at Steward’s physician group

entertainment

entertainment

knowledge

Sports medicine is finally prioritizing gender equality

FDA proposes changes to key medical devices approval pathway

State Dept. review finds Biden bears some blame for Afghanistan failures

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Guidelines to prevent youth baseball injuries need more muscle

How housing is health care on Long Island

Hollywood unions extend contract negotiations for actors

How to make the FDA’s new prescription one

BioMarin wins approval for gene therapy to treat hemophilia A

Food makers to regulators: Ultra

focus

First Opinion on colorectal cancer screening: letter and response

What to make of Biden’s latest efforts on cancer research

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Regeneron agrees to White House price limits on anti

IRA could hurt research into orphan drugs for rare diseases

Regeneron agrees to White House price limits on anti

hotspot

entertainment

hotspot

hotspot